Structure | Chemical Name | CAS | MF |
|
N-octanoyl-asparaginyl-tyrosyl-threoninamide
|
117978-19-5
|
C25H39N5O7
|
|
gallidermin
|
117978-77-5
|
C98H141N25O23S4
|
|
(E)-N-<1-(3-pyridyl)ethylidene>-4H-1,2,4-triazol-4-amine
|
117979-29-0
|
C9H9N5
|
|
4-CHLOROMETHOXY-BUT-1-ENE
|
117983-52-5
|
C5H9ClO
|
|
Benzenesulfonic acid, hydroxy-, monosodium salt, polymer with benzenamine, formaldehyde, 1,3,5-triazine-2,4,6-triamine and urea, bisulfited
|
117985-54-3
|
|
|
TNPAL-SPHINGOMYELIN
|
117985-56-5
|
C41H73N6O12P
|
|
ENANTIO-PAF (C16)
|
117985-57-6
|
C26H54NO7P
|
|
N-Ethenylformamide polymer with ethenamine, sulfate
|
117985-59-8
|
C5H12N2O5S
|
|
2-Oxepanone, homopolymer, oxydi-2,1-ethanediyl ester, bis(hydrogen 1,2-benzenedicarboxylate)
|
117985-60-1
|
C18H26O9
|
|
5-MERCAPTO-4-PENTYL-4H-1,2,4-TRIAZOL-3-OL
|
117987-05-0
|
C7H13N3OS
|
|
Dipyrazino[2,3-b:2,3-e]pyrazine, 1,5-dihydro- (6CI)
|
117987-19-6
|
C8H6N6
|
|
Pigment red 257
|
117989-29-4
|
C8H3Cl4N3O
|
|
OM 89
|
117989-72-7
|
|
|
3,5-Hexadien-2-one, 4,5-dimethyl-, (Z)- (9CI)
|
117992-40-2
|
C8H12O
|
|
dopamine, N-benzyloxycarboxyl-Lys-Pro-amide-
|
117992-59-3
|
C27H34N4O7
|
|
dopamine, Lys-Pro-amide-
|
117992-60-6
|
C19H28N4O5
|
|
dopamine, Gly-Pro-amide-
|
117992-61-7
|
C15H19N3O5
|
|
2-HYDROXYMETHYL-4-(3-METHOXYPROPOXY)PYRIDINE
|
117992-97-9
|
C10H15NO3
|
|
etoxadrol-2-isothiocyanate
|
117994-64-6
|
C17H22N2O2S
|
|
1,2-di-6,9-hexacosadienoylphosphatidylcholine
|
117994-73-7
|
C60H112NO8P
|
|
Boc-DL-Glu(OBzl)-OH
|
117997-81-6
|
C17H23NO6
|
|
2,7-Dioxabicyclo[3.2.0]hept-3-ene, 6-ethynyl-6-methyl-, (1alpha,5alpha,6beta)- (9CI)
|
117999-92-5
|
C8H8O2
|
|
2-Chloromethyl-5-methyl-imidazo[1,2-a]pyridine
|
118000-39-8
|
C9H9ClN2
|
|
2-(CHLOROMETHYL)-6-METHYLIMIDAZO[1,2-A]PYRIDINE HYDROCHLORIDE
|
118000-40-1
|
C9H9ClN2
|
|
2-(CHLOROMETHYL)-7-METHYLIMIDAZO[1,2-A]PYRIDINE
|
118000-41-2
|
C9H9ClN2
|
|
2-(Chloromethyl)-6-(trifluoromethyl)-imidazo[1,2-a]pyridine
|
118000-42-3
|
C9H6ClF3N2
|
|
IMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE
|
118000-43-4
|
C8H6N2O
|
|
5-METHYLIMIDAZO[1,2-A]PYRIDINE-2-CARBALDEHYDE
|
118000-44-5
|
C9H8N2O
|
|
4-IMIDAZO[1,2-A]PYRIDIN-2-YLBENZALDEHYDE
|
118000-48-9
|
C14H10N2O
|
|
2-(4-BROMOPHENYL)-6-NITROIMIDAZO[1,2-A]PYRIDINE
|
118000-56-9
|
C13H8BrN3O2
|
|
2-(4-BROMOPHENYL)-6-IODOIMIDAZO(1 2-A)P&
|
118000-66-1
|
C13H8BrIN2
|
|
4-IMIDAZO[2,1-B]THIAZOL-6-YL-BENZONITRILE
|
118001-67-5
|
C12H7N3S
|
|
2-(4-IODOPHENYL)IMIDAZO[1,2-A]PYRIMIDINE
|
118001-69-7
|
C12H8IN3
|
|
4-[(1-METHYL-1H-IMIDAZOL-2-YL)METHOXY]BENZALDEHYDE
|
118001-71-1
|
C12H12N2O2
|
|
4-(PYRIDIN-3-YLMETHOXY)BENZALDEHYDE
|
118001-72-2
|
C13H11NO2
|
|
4-(PYRIDIN-4-YLMETHOXY)BENZALDEHYDE
|
118001-73-3
|
C13H11NO2
|
|
4-(1,3-THIAZOL-4-YLMETHOXY)BENZALDEHYDE
|
118001-74-4
|
C11H9NO2S
|
|
4-(imidazo[1,2-a]pyridin-2-ylmethoxy)benzaldehyde
|
118001-76-6
|
C15H12N2O2
|
|
7,8-epoxysinogenin 3-methylglycosides
|
118004-72-1
|
C30H42O10
|
|
3-METHOXY-2-TRIMETHYLSILYLPYRIDINE
|
118005-97-3
|
C9H15NOSi
|
|
3-METHOXY-4-TRIMETHYLSILYLPYRIDINE
|
118005-98-4
|
C9H15NOSi
|
|
tracheal cytotoxin, Bordetella pertussis
|
118013-66-4
|
|
|
2-Methyl-1,1'-binaphthalene
|
118018-45-4
|
C21H16
|
|
ETHYL 5-AMINO-1H-IMIDAZOLE-4-CARBOXYLATE HYDROCHLORIDE
|
118019-42-4
|
C6H10ClN3O2
|
|
sulfuric acid mono-(2-amino-6-oxo-1,6-dihydro-pyrimidin-5-yl ester)
|
118019-45-7
|
C4H5N3O5S
|
|
Imidocarbonic acid, chloro-, cyclic chloroethylene ester (6CI)
|
118020-37-4
|
C3H3Cl2NO2
|
|
DELTA 7 CIS NONADECENOIC ACID
|
118020-79-4
|
C19H36O2
|
|
1,2,4-Triazolidine-4-acetamide, 1-butyl-alpha-(2,2-dimethyl-1-oxopropyl)-N-[5-[[3-(dodecylsulfonyl)-2-methyl-1-oxopropy] amino-2-methoxyphenyl]-3,5-dioxo-2-phenyl-
|
118020-93-2
|
C42H63N5O8S
|
|
N-[5-[[3-(Dodecylsulfonyl)-2-methylpropionyl]amino]-2-methoxyphenyl]-4,4-dimethyl-3-oxopentanamide
|
118021-16-2
|
C30H50N2O6S
|
|
L-Lysine, 5-fluoro- (9CI)
|
118021-33-3
|
C6H13FN2O2
|
|
L-Lysine, 4-oxo- (9CI)
|
118021-34-4
|
C6H12N2O3
|
|
O-(2-AMINOETHYL)-L-SERINE HYDROCHLORIDE
|
118021-35-5
|
C5H13ClN2O3
|
|
ALPHA-NEUNAC-[2->6]-BETA-GAL-[1->4]-BETA-GLCNAC-[1->3][BETA-GAL-(1->4)-BETA-GLCNAC(1->6)]-BETA-GAL-[1->4]-GLC
|
118023-83-9
|
C51H85N3O39
|
|
O-beta-D-galactofuranosyl-(1->3)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)- D-Glucose
|
118023-85-1
|
C40H68N2O31
|
|
O-(N-acetyl-alpha-neuraminosyl)-(2->3)-O-beta-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)- D-Gluc
|
118023-86-2
|
C51H85N3O39
|
|
blumeatin
|
118024-26-3
|
C16H14O6
|
|
N-Benzoyl-O,a-dimethyl-DL-tyrosine
|
118024-43-4
|
C18H19NO4
|
|
3,7-Dihydro-1-methyl-3-propyl-1H-purine-2,6-dione
|
118024-67-2
|
C9H12N4O2
|
|
1,2-Di-(heptacosadiynoyl)-sn-glycero-3-phosphocholine
|
118024-74-1
|
|
|
PHM-27 (HUMAN)
|
118025-43-7
|
C135H214N34O40S
|
|
3H-1,2,4-Triazole-3-thione, 1-acetyl-5-amino-1,2-dihydro- (9CI)
|
118025-67-5
|
C4H6N4OS
|
|
10-Hydroxy-7,10-dimethyl-4-(1-methylethenyl)-14-oxabicyclo[11.2.1]hexadeca-1(16),7-diene-6,9,15-trione
|
118025-71-1
|
C20H26O5
|
|
6-METHYL-N,N-DIMETHYL-2-(4-METHYLPHENYL)-2-HYDROXYIMIDAZO[1,2-ALPHA]PYRIDINE-3-ACETAMIDE
|
118026-14-5
|
C19H21N3O2
|
|
[4-(Ethoxycarbonyl)butyl]triphenylphosphonium bromide
|
118026-77-0
|
C25H28BrO2P
|
|
4-O-Methylgrifolic acid
|
118040-60-1
|
C24H34O4
|
|
O-(N-acetyl-a-neuraminosyl)-(2->6)-O-b-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1->3)-O-[O-6-deoxy-a-L-galactopyranosyl-(1->3)-O-[b-D-galactopyranosyl-(1->4)]-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl-(1->6)]-O-b-D-mannopyr
|
118045-31-1
|
C57H95N3O43
|
|
cyclopentenylcytosine 6-triphosphate
|
118045-71-9
|
C10H16N3O13P3
|
|
5-(2-CHLOROPHENYL)-2,4-DIHYDRO-2-PHENYL-3H-PYRAZOL-3-ONE
|
118049-75-5
|
C15H11ClN2O
|
|
2-Penten-2-ol, 4,4-dimethyl- (9CI)
|
118051-64-2
|
C7H14O
|
|
ZoledronicAcid
|
118054-40-3
|
C5H10N2O6P2
|
|
(1-METHYL-1H-IMIDAZOL-2-YL)-ACETIC ACID
|
118054-54-9
|
C6H8N2O2
|
|
1H-Pyrazole-3-acetic acid, hydrochloride
|
118054-57-2
|
C5H7ClN2O2
|
|
C-PYRAZOLO[1,5-A]PYRIDIN-3-YL-METHYLAMINE
|
118054-99-2
|
C8H9N3
|
|
Pyrazolo[1,5-a]pyridine-3-acetonitrile
|
118055-01-9
|
C9H7N3
|
|
ethyl 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-3-carboxylate
|
118055-06-4
|
C10H14N2O2
|
|
clearfil SC-II
|
118057-75-3
|
|
|
3-O-Decladinosyl-6-O-Methylerythronolide A
|
118058-74-5
|
C30H55NO10
|
|
Z-thioPro-thiazolidine
|
118059-38-4
|
C15H18N2O3S2
|
|
N-(4-benzoylphenyl)propanamide
|
118059-82-8
|
C16H15NO2
|
|
4-NITRODIBENZO-18-CROWN-6, 97
|
118060-27-8
|
C20H23NO8
|
|
3H-Pyrrol-3-one,1-ethyl-1,2-dihydro-2-methyl-(9CI)
|
118060-72-3
|
C7H11NO
|
|
1H-Pyrrol-3-ol,1-ethyl-2-methyl-(9CI)
|
118060-82-5
|
C7H11NO
|
|
beta-casokinin 10
|
118060-90-5
|
C53H85N15O14
|
|
6H-1,3-Thiazine-5-carboxylicacid,2-ethoxy-,methylester(9CI)
|
118062-03-6
|
C8H11NO3S
|
|
2,3,4-Trimethoxyphenylboronic acid
|
118062-05-8
|
C9H13BO5
|
|
Bicyclo[2.2.1]heptane-1-carbonyl chloride, 4,7,7-trimethyl-3-oxo- (9CI)
|
118063-57-3
|
C11H15ClO2
|
|
H-SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER-OH
|
118068-30-7
|
C43H68N12O16
|
|
3-methyl-5-(2-iodovinyl)-2'-deoxyuridine
|
118068-34-1
|
C12H15IN2O5
|
|
Dihydroprehelminthosporol
|
118069-95-7
|
C15H26O2
|
|
2-{[2-(4-methylbenzoyl)hydrazino]carbonyl}benzoic acid
|
118071-17-3
|
C16H14N2O4
|
|
2-{[2-(4-methoxybenzoyl)hydrazino]carbonyl}benzoic acid
|
118071-18-4
|
C16H14N2O5
|
|
2-{[2-(4-bromobenzoyl)hydrazino]carbonyl}benzoic acid
|
118071-19-5
|
C15H11BrN2O4
|
|
H-SER-GLN-ASN-TYR-PRO-ILE-VAL-OH
|
118071-31-1
|
C37H57N9O12
|
|
Zoledronic acid
|
118072-93-8
|
C5H10N2O7P2
|
|
Clarithromycin Impurity Q (10 mg) (N-oxide clarithromycin)
|
118074-07-0
|
C38H69NO14
|
|
Umbelliferone + BSTFA
|
118074-57-0
|
C12H14O3Si
|
|
2,4-Dioxo-23,24-dinor-3-oxa-D:A-friedoolean-1(10),5,7-trien-29-oic acid methyl ester
|
118075-30-2
|
C28H36O5
|
|
SDZ EAB 515
|
118077-09-1
|
C16H18NO5P
|
|
6-(6-AMino-hexyldisulfanyl)-hexylaMine hydrochloride
|
118077-46-6
|
C12H29ClN2S2
|
|
7-CYANO-4-HYDROXY-3-QUINOLINECARBOXYLIC ACID
|
118078-26-5
|
C11H6N2O3
|